Finding MAPT Mutations in Frontotemporal Dementia and Other Tauopathies

Area of Science:

• Molecular Genetics
• Genomics
• Biochemistry

Background:

• Sanger sequencing is a foundational method for identifying single nucleotide DNA variants in genomic DNA.
• Mutations in the MAPT gene are associated with various neurodegenerative diseases.
• Aberrant splicing of MAPT exon 10 is a common pathogenic mechanism.

Purpose of the Study:

• To describe the detection of MAPT mutations using Sanger sequencing.
• To outline the application of exon trapping to assess splicing efficiency.
• To evaluate the impact of novel DNA variants on MAPT exon 10 splicing.

Main Methods:

• Polymerase chain reaction (PCR) amplification of patient genomic DNA.
• Bidirectional Sanger sequencing for mutation detection.
• Exon trapping involving cloning genomic DNA into an expression vector, transfection into human cell lines, and analysis of splicing products via reverse-transcriptase PCR and agarose gel electrophoresis.

Main Results:

• Successful detection of MAPT mutations using the described Sanger sequencing approach.
• Demonstration of exon trapping as a viable method to examine splicing alterations.
• Assessment of how specific DNA variants influence the splicing efficiency of MAPT exon 10.

Conclusions:

• Sanger sequencing and exon trapping are effective techniques for investigating MAPT mutations.
• These methods are crucial for understanding the molecular basis of diseases caused by MAPT variants.
• The study provides a framework for analyzing the functional consequences of genetic variations on gene splicing.